000168304 001__ 168304
000168304 005__ 20240229133603.0
000168304 0247_ $$2doi$$a10.3390/cancers13071623
000168304 0247_ $$2altmetric$$aaltmetric:104999742
000168304 0247_ $$2pmid$$a33915693
000168304 037__ $$aDKFZ-2021-00815
000168304 082__ $$a610
000168304 1001_ $$aSeydel, Florian$$b0
000168304 245__ $$aEfficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort Study
000168304 260__ $$aBasel$$bMDPI$$c2021
000168304 3367_ $$2DRIVER$$aarticle
000168304 3367_ $$2DataCite$$aOutput Types/Journal article
000168304 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1618987783_19147
000168304 3367_ $$2BibTeX$$aARTICLE
000168304 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000168304 3367_ $$00$$2EndNote$$aJournal Article
000168304 500__ $$a#EA:F100#
000168304 536__ $$0G:(DE-HGF)POF4-316$$a316 - Infektionen, Entzündung und Krebs (POF4-316)$$cPOF4-316$$fPOF IV$$x0
000168304 588__ $$aDataset connected to CrossRef, Journals: inrepo01.inet.dkfz-heidelberg.de
000168304 7001_ $$0P:(DE-He78)3877ae274d0271d6bf311bb46539f013$$aDelecluse, Susanne$$b1$$eFirst author$$udkfz
000168304 7001_ $$aZeier, Martin$$b2
000168304 7001_ $$0P:(DE-He78)457c042884c901eb0a02c18bb1d30103$$aHolland-Letz, Tim$$b3$$udkfz
000168304 7001_ $$aHaag, Georg Martin$$b4
000168304 7001_ $$aBerger, Anne Katrin$$b5
000168304 7001_ $$aGrün, Barbara Christine$$b6
000168304 7001_ $$aBougatf, Nina$$b7
000168304 7001_ $$aHohenfellner, Markus$$b8
000168304 7001_ $$aDuensing, Stefan$$b9
000168304 7001_ $$aJäger, Dirk$$b10
000168304 7001_ $$aZschäbitz, Stefanie$$b11
000168304 773__ $$0PERI:(DE-600)2527080-1$$a10.3390/cancers13071623$$gVol. 13, no. 7, p. 1623 -$$n7$$p1623$$tCancers$$v13$$x2072-6694$$y2021
000168304 909CO $$ooai:inrepo02.dkfz.de:168304$$pVDB
000168304 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3877ae274d0271d6bf311bb46539f013$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000168304 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)457c042884c901eb0a02c18bb1d30103$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000168304 9130_ $$0G:(DE-HGF)POF3-316$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfections and cancer$$x0
000168304 9131_ $$0G:(DE-HGF)POF4-316$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfektionen, Entzündung und Krebs$$x0
000168304 9141_ $$y2021
000168304 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCERS : 2018$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2020-09-11
000168304 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCERS : 2018$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2020-09-11
000168304 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-09-11
000168304 9201_ $$0I:(DE-He78)F100-20160331$$kF100$$lF100 Pathologie infektionsbedingter Tumoren$$x0
000168304 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x1
000168304 980__ $$ajournal
000168304 980__ $$aVDB
000168304 980__ $$aI:(DE-He78)F100-20160331
000168304 980__ $$aI:(DE-He78)C060-20160331
000168304 980__ $$aUNRESTRICTED